Idiopathic Hypogonadotropic Hypogonadism
Idiopathic Hypogonadotropic Hypogonadism
Also known as:IHH, Congenital Hypogonadotropic Hypogonadism (CHH), Kallmann Syndrome (KS, with olfactory abnormalities), Normosmic IHH (nIHH)
Idiopathic Hypogonadotropic Hypogonadism is a rare endocrine disorder caused by impaired function of hypothalamic gonadotropin-releasing hormone (GnRH) neurons, leading to insufficient secretion of gonadotropins and resulting in hypogonadism.
Start Here
A quick guide to the next step: which department to start with, what to prepare, and what to ask.
For children presenting with short stature or delayed sexual development, evaluation at a pediatric endocrinology or pediatric genetics/metabolism department is recommended. For adolescents presenting with absence of sexual development, consultation with pediatric endocrinology or reproductive endocrinology is recommended. Adults presenting with infertility or sexual dysfunction may consult urology/andrology (males) or reproductive endocrinology (females). Those with olfactory abnormalities should also see an ENT specialist. Those with a family history may consider genetic counseling.
Idiopathic Hypogonadotropic Hypogonadism (IHH) is a congenital disorder affecting the hypothalamic-pituitary-gonadal axis. Due to impaired function of hypothalamic GnRH neurons, GnRH synthesis, secretion, or action is impaired, leading to reduced secretion of pituitary gonadotropins (LH, FSH) and subsequent hypogonadism. It is classified into two types based on the presence of olfactory abnormalities: Kallmann syndrome (KS) when accompanied by reduced or absent sense of smell, and normosmic IHH (nIHH) when smell is normal. IHH is a genetically heterogeneous disorder with more than 30 related genes identified.
Yes, there are treatment pathways including puberty induction, long-term hormone replacement, and fertility treatment. Treatment goals differ, and the approach varies accordingly, requiring planning by endocrinology or reproductive endocrinology specialists.
Yes, IHH is a genetically heterogeneous disorder, and various gene mutations have been identified as causes, including GNRH1, GNRHR, KISS1, KISS1R, FGFR1, PROK2, PROKR2, CHD7, TAC3, TACR3, and others. Most follow autosomal dominant or recessive inheritance, with a few being X-linked (such as Kallmann syndrome caused by ANOS1/KAL1 gene mutations). Known pathogenic mutations can be detected in approximately 40%~50% of familial cases and approximately 17% of sporadic cases.
IHH has an insidious onset and is difficult to identify before puberty. Some patients may be missed due to atypical symptoms (such as partial hypogonadism). The reduced sense of smell in Kallmann syndrome is sometimes dismissed as rhinitis or common cold. Primary care physicians may lack experience in differentiating causes of delayed puberty, leading to delayed targeted examinations. Some female patients present with amenorrhea but are often misdiagnosed with functional amenorrhea or polycystic ovary syndrome.
This page helps patients and families organize care leads. It does not replace a clinician’s diagnosis or treatment plan. For testing, medication, referrals, emergency care, and support applications, follow qualified clinicians, medical institutions, support organizations, and official sources.
Diagnosis Path
Organized around the practical patient journey: identify clues, avoid common delays, then prepare for care.
When to Suspect It
- No development of secondary sexual characteristics during puberty (males: no testicular enlargement, penile development, or growth of pubic/axillary hair; females: no breast development, no menarche)
- Normal growth velocity but no pubertal development, with bone age lagging behind chronological age
- Reduced or complete loss of sense of smell (especially around puberty)
- History of micropenis or cryptorchidism in males
- Primary amenorrhea (females with no menarche after age 14 and no secondary sexual characteristics)
- Family history of gonadotropin-releasing hormone deficiency
- Decreased libido, erectile dysfunction, or infertility in adults
Common Wrong Turns
- Attributing delayed puberty to constitutional delay of growth and puberty (CDGP, or 'late bloomer'), without performing hormone tests
- Attributing olfactory reduction in Kallmann syndrome to rhinitis or common cold, delaying diagnosis
- Female patients misdiagnosed with polycystic ovary syndrome or functional amenorrhea, without systematic hormone evaluation
- Focusing only on gonadal function while neglecting olfactory screening and pituitary imaging
- Managing male micropenis or cryptorchidism locally without investigating the hypothalamic-pituitary-gonadal axis
Departments to Start With
- Pediatric endocrinology or pediatric genetics/metabolism department (children/adolescent patients)
- Reproductive endocrinology department (adolescent and adult patients)
- Urology/Andrology department (male patients)
- ENT department (for olfactory disorders)
- Medical genetics or reproductive medicine department (genetic counseling and family analysis)
Before the Visit
- Detailed medical history: growth and development history, sexual development history, olfactory history, family history
- Physical examination: height, weight, growth velocity, Tanner staging of secondary sexual characteristics, olfactory testing
- Basic hormone tests: LH, FSH, testosterone (males), estradiol (females), inhibin B
- GnRH stimulation test: assessing pituitary gonadotropin reserve function
- Olfactory testing and sinus CT/MRI: assessing olfactory function and olfactory bulb development
- Pituitary MRI: excluding intracranial space-occupying lesions or developmental abnormalities
- Genetic testing: targeted gene panel or whole exome sequencing (can establish genetic diagnosis)
- Bone age assessment
- Testicular/ovarian ultrasound (when necessary)
Tests to Ask About
- Sex hormone panel (LH, FSH, testosterone/estradiol)
- GnRH stimulation test
- Olfactory testing
- Pituitary MRI
- Genetic testing (IHH-related genes)
- Bone age X-ray
Questions for the Doctor
- Is this more likely constitutional delay of puberty or hypogonadotropic hypogonadism? What is the basis?
- Are there olfactory abnormalities or other syndromic clues? What imaging, hormone, and genetic tests are needed?
- What are the current treatment goals: puberty induction, long-term replacement, or future fertility?
- How should treatment efficacy, side effects, and bone health be monitored?
- What genetic counseling is needed for family members and future family planning?
Basic Information
Medical Notes
More complete medical explanations are kept here for discussion with clinicians.